Skip to main content

A phase 3, randomized, double-blind, placebo-controlled, parallel-arm study to evaluate the efficacy and safety of RZ358 in patients with congenital hyperinsulinism.

Open
  • Protocol code: RZ358-301
  • EudraCT code: _
  • Research group: Growth and Development
  • Service: General Pediatrics and Specialties
  • Principal investigator:  Clemente Leon, Maria
  • Pathology: Malalties endocrines, nutricionals i metabòliques
  • Phase: Fase III